Pharma Capital
EPIC: HIK
Market: AIM:HIK
OTC:HKMPF
52-week High/Low: 2,346.00p / 1,101.00p
Sector: Pharma & Biotech
Market Cap: 2,731.35M
Website: www.hikma.com

Hikma Pharmaceuticals PLC is a pharmaceutical company engaged the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms.

Hikma Pharmaceuticals

www.hikma.com

Interactive graph

col 3
col 4
col 5
col 6

Hikma Pharmaceuticals Timeline

View All

Columns Including HIK

VIEW ALL

Market Reports Including HIK

VIEW ALL

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.